Vetter Pharma International GmbH | 12-Apr-2016
| Product Brochure
With more sophisticated therapies coming to market, manufacturers need more options for complex, sensitive molecules. Vetter-Ject® is a patented, ready-to-use...
Risk-based monitoring is coming into its own as an effective and pragmatic methodology to enhance patient safety while delivering significant efficiency...
World Courier | 22-Mar-2016
| Technical / White Paper
Orphan drugs, those medications that are typically produced in small quantities for limited patient populations, are growing in importance worldwide. Once...
Pfizer CentreOne™ is a global CMO that focuses on API synthesis and sterile injectables fill-finish. For 40+ years, we’ve manufactured complex compounds...
Recipharm AB | 10-Mar-2016
| Technical / White Paper
Recipharm already has experience in serialised production. From our UK facility in Manchester over 40 batches have been delivered from a fully validated...
The importance of Pharmacovigilance (PV) as a science and its role in effective patient care in clinical practice and public health is growing. Patient-centeredness...
Alliance for Clinical Trials in Oncology Foundation, a nonprofit organization that supports the mission to reduce the impact of cancer, has selected multiple...
Contaminants leaching from pharmaceutical container systems and product packaging has increased the awareness of the health risks posed by extractables...
The global pharmaceutical industry will have spent more than $10 billion on cold chain logistics in 2015, getting products and clinical trial supplies...
Drug development cost, lengthier development cycles, and identifying a suitable delivery platform were identified as the top three business challenges...
It’s time to look back and see how our predictions for this year fared, and take another look at the things we have written about since then.We examine...
Piramal Healthcare Ltd | Recorded the 08-Dec-2015 | Webinar
Recently, Route Scouting (RS) for preclinical and clinical development has emerged as an important area of interest. Identifying the most efficient route....
World Courier | 17-Nov-2015
| Technical / White Paper
Rare diseases can affect as few as one in a million people, but for those unfortunate enough to experience them, medication therapy is often their only...
SANOFI - CEPiA | 09-Nov-2015
| Technical / White Paper
From a unique state-of-the-art platform for development and scale-up of Peptides and Oligonucleotides in Frankfurt (Germany), CEPiA offers customized services...
The landscape of the clinical trial supply chain is changing throughout the world. Patient centricities and immune, cell and gene therapies are now the...
